The September quarter results showcased Syrma's operational strength, with net sales climbing 37.60% year-on-year to ₹1,145.89 crores, whilst sequential growth of 21.39% quarter-on-quarter demonstrated accelerating momentum. The company's ability to expand operating margins to 10.06% from 8.52% in the year-ago period, despite inflationary pressures in the manufacturing sector, underscores improving operational efficiency and pricing power.
Following the results announcement, the stock has exhibited volatility, currently trading at ₹725.40, approximately 20.24% below its 52-week high of ₹909.50. The one-year return of 43.83% significantly outpaces the Sensex's 7.88% gain, delivering an alpha of 35.95 percentage points, though recent three-month performance shows an 11.20% decline against the benchmark's 2.86% drop.
| Quarter | Sep'25 | Jun'25 | Mar'25 | Dec'24 | Sep'24 |
|---|---|---|---|---|---|
| Net Sales (₹ Cr) | 1,145.89 | 943.98 | 924.36 | 869.70 | 832.74 |
| QoQ Growth | +21.39% | +2.12% | +6.28% | +4.44% | -28.21% |
| YoY Growth | +37.60% | -18.62% | -19.09% | — | — |
| Cons. Net Profit (₹ Cr) | 64.06 | 49.74 | 65.44 | 48.79 | 36.24 |
| QoQ Growth | +28.79% | -23.99% | +34.13% | +34.63% | +87.77% |
| YoY Growth | +76.77% | +157.72% | +87.29% | — | — |
| Operating Margin (Excl OI) | 10.06% | 9.18% | 11.63% | 9.15% | 8.52% |
| PAT Margin | 5.79% | 5.29% | 7.73% | 6.10% | 4.76% |
Financial Performance: Margin Expansion Drives Profitability
Syrma's Q2 FY26 financial performance revealed a company hitting its operational stride. Net sales of ₹1,145.89 crores represented not only a robust 37.60% year-on-year increase but also a sequential acceleration of 21.39% from Q1 FY26's ₹943.98 crores. This sequential momentum is particularly noteworthy given the manufacturing sector's typical seasonal patterns.
The company's operating profit excluding other income surged to ₹115.24 crores, translating to a margin of 10.06%—a significant improvement from 8.52% in the year-ago period and 9.18% in the preceding quarter. This 154 basis point year-on-year margin expansion demonstrates effective cost management and operational leverage as the company scales its revenue base. Employee costs remained well-controlled at ₹51.47 crores, representing 4.49% of sales, compared to 5.52% in Q2 FY25.
Interest costs declined marginally to ₹12.63 crores from ₹13.59 crores year-on-year, reflecting prudent financial management. The tax rate normalised to 25.88% in Q2 FY26 from 21.78% in the year-ago quarter, bringing the effective rate closer to statutory levels. Net profit after tax stood at ₹66.34 crores on a standalone basis, whilst consolidated PAT reached ₹64.06 crores, indicating minimal minority interests or associate company losses.
On a half-yearly basis for H1 FY26 (April-September 2025), the company posted cumulative consolidated net profit of ₹113.80 crores on revenues of ₹2,089.87 crores, representing strong operational performance in the first half of the fiscal year. The quality of earnings appears robust, with operating cash flow generation supporting the profit growth trajectory.
Operational Challenges: Return Ratios Remain Subdued
Despite impressive top-line and bottom-line growth, Syrma's return metrics reveal areas requiring improvement. The company's average return on equity (ROE) stands at a modest 7.32%, whilst the latest ROE for FY25 was 8.18%—significantly below the double-digit returns typically expected from quality manufacturing businesses. This suggests that whilst the company is growing profits, capital efficiency remains below optimal levels.
Return on capital employed (ROCE) averaged 9.50% over recent years, improving to 12.83% in the latest fiscal year. Whilst the upward trajectory is encouraging, these returns remain modest compared to industry leaders who typically generate ROCE above 15-20%. The relatively low returns reflect the capital-intensive nature of electronics manufacturing and the company's ongoing investment phase to expand capacity and capabilities.
Capital Efficiency Concerns
Syrma's ROE of 7.32% and ROCE of 9.50% (average) lag behind manufacturing sector benchmarks. The company's sales to capital employed ratio of 1.36x indicates moderate asset turnover. As the business scales and newer capacities mature, investors should monitor whether return ratios improve towards mid-teens levels to justify the premium valuation multiple.
On the positive side, the company maintains a net cash position with an average net debt to equity ratio of -0.15, indicating zero net debt. Total long-term debt stood at ₹89.81 crores as of March 2025 against shareholder funds of ₹1,749.96 crores, providing substantial financial flexibility. The debt-to-EBITDA ratio of 2.22 times is manageable, whilst the EBIT-to-interest coverage ratio of 5.41 times offers adequate cushion for servicing obligations.
Working capital management presents a mixed picture. Trade payables surged to ₹1,574.39 crores in FY25 from ₹1,223.24 crores in FY24, reflecting the company's growing scale but also raising questions about supplier payment terms and potential working capital stress. The debtors turnover ratio declined to a concerning low of 2.05 times in H1 FY26, suggesting slower collection cycles that merit close monitoring.
Industry Context: Electronics Manufacturing Tailwinds
Syrma operates in India's rapidly expanding electronics manufacturing services (EMS) sector, benefiting from the government's Production Linked Incentive (PLI) schemes and the broader "Make in India" initiative. The company provides end-to-end manufacturing solutions across consumer electronics, industrial electronics, automotive electronics, and other segments, positioning it to capture growth across multiple end-markets.
The Indian EMS industry has witnessed robust growth driven by multinational companies diversifying their supply chains away from China, increased domestic demand for electronics, and supportive government policies. Syrma's 36.44% five-year sales compound annual growth rate (CAGR) significantly outpaces the broader industrial manufacturing sector, which delivered negative 4.87% returns over the past year, demonstrating the company's ability to gain market share in a growing industry.
However, the sector faces challenges including intense competition, margin pressures from component price volatility, high capital intensity, and dependence on a few large customers. The company's ability to maintain and expand its customer base whilst improving return ratios will be critical to sustaining its growth trajectory.
Peer Comparison: Premium Valuation Relative to Competitors
Syrma's valuation metrics position it at the higher end of its peer group, reflecting market expectations of superior growth but also raising questions about sustainability. At a P/E ratio of 60.87x trailing earnings, the stock trades in line with Kaynes Technology (60.24x) but below Lakshmi Machine Works' 127.33x multiple. However, it commands a significant premium to Jupiter Wagons (48.69x) and Jyoti CNC Automation (53.07x).
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Div. Yield (%) |
|---|---|---|---|---|---|
| Syrma SGS Tech. | 60.87 | 4.98 | 7.32 | -0.15 | 0.21 |
| Kaynes Tech | 60.24 | 4.87 | 9.72 | -0.04 | — |
| Jyoti CNC Auto. | 53.07 | 10.03 | 18.64 | 0.29 | — |
| LMW | 127.33 | 5.46 | 9.95 | -0.62 | 0.21 |
| Jupiter Wagons | 48.69 | 5.00 | 13.69 | 0.02 | 0.30 |
| Tega Industries | 53.77 | 8.61 | 16.45 | -0.07 | 0.10 |
The comparison reveals a critical concern: Syrma's ROE of 7.32% is the lowest amongst its peers, with competitors like Jyoti CNC Automation (18.64%), Tega Industries (16.45%), and Jupiter Wagons (13.69%) delivering substantially higher returns on shareholder capital. This ROE disadvantage makes the valuation premium difficult to justify on fundamental grounds alone.
Syrma's price-to-book ratio of 4.98x appears reasonable compared to Jyoti CNC's 10.03x and Tega's 8.61x, but the company's lower ROE means it generates less profit per unit of book value. The dividend yield of 0.21% matches LMW but trails Jupiter Wagons' 0.30%, reflecting the company's preference to retain earnings for growth investments rather than distribute cash to shareholders.
The company's net cash position (negative debt-to-equity of -0.15) provides a competitive advantage, offering financial flexibility that peers with positive leverage lack. This balance sheet strength positions Syrma to pursue growth opportunities without dilution or excessive financial risk.
Valuation Analysis: Expensive Territory Despite Growth
Syrma's current valuation of ₹725.40 per share translates to demanding multiples across various metrics. The P/E ratio of 60.87x represents a significant premium to the industrial manufacturing sector average of 49x, reflecting market expectations of continued high growth. However, this premium appears stretched given the company's modest return ratios and recent earnings volatility.
The enterprise value to EBITDA multiple of 34.87x and EV/EBIT of 44.39x indicate expensive valuations by historical standards. The EV/Sales ratio of 3.49x suggests the market is pricing in substantial margin expansion and profit growth over the coming years. The price-to-book ratio of 4.98x, whilst lower than some peers, still represents a material premium to book value that requires sustained ROE improvement to justify.
The PEG ratio of 0.61x appears attractive on the surface, suggesting the stock is reasonably priced relative to its growth rate. However, this metric should be interpreted cautiously given the volatility in quarterly earnings and the sustainability questions around maintaining 36% revenue growth rates as the company scales.
The stock's 52-week range of ₹355.05 to ₹909.50 illustrates significant volatility, with the current price sitting 20.24% below the peak. This correction from highs may reflect profit-booking after the stock's 180.02% three-year return, or growing investor concerns about valuation sustainability. The proprietary Mojo Score of 57/100 with a "HOLD" rating suggests the risk-reward balance has shifted from earlier "BUY" recommendations as valuations have expanded.
Shareholding Pattern: Promoter Reduction Raises Questions
The shareholding pattern reveals notable changes over recent quarters that warrant investor attention. Promoter holding declined from 46.52% in March 2025 to 42.72% in December 2025, representing a reduction of 3.80 percentage points over three quarters. The most significant drop occurred between June and August 2025, when promoter stake fell by 3.45 percentage points from 46.42% to 42.97%.
| Shareholder Category | Dec'25 | Sep'25 | Jun'25 | Mar'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter Holding | 42.72% | 42.97% | 46.42% | 46.52% | -0.25% |
| FII Holding | 6.47% | 7.02% | 6.34% | 6.20% | -0.55% |
| Mutual Fund Holding | 10.00% | 10.65% | 6.83% | 5.44% | -0.65% |
| Insurance Holdings | 4.83% | 4.48% | 0.73% | 0.08% | +0.35% |
| Other DII Holdings | 1.06% | 1.26% | 1.59% | 2.21% | -0.20% |
| Non-Institutional | 34.92% | 33.62% | 38.09% | 39.55% | +1.30% |
Whilst promoter stake reduction often raises concerns about insider confidence, the context matters. The reduction could reflect planned diversification, estate planning, or compliance with minimum public shareholding norms. Importantly, promoters still retain a substantial 42.72% stake, demonstrating continued alignment with shareholder interests. Zero promoter pledging further reinforces financial stability.
Institutional holdings paint a mixed picture. Mutual fund ownership surged impressively from 5.44% in March 2025 to 10.65% by September 2025, reflecting growing domestic institutional confidence. However, this declined slightly to 10.00% by December 2025. Insurance company holdings jumped dramatically from just 0.08% in March 2025 to 4.83% by December 2025, indicating strong conviction from long-term institutional investors.
Foreign institutional investor (FII) holdings have remained relatively stable around 6-7%, though showing a slight declining trend from 7.02% in September to 6.47% in December 2025. The increase in non-institutional holdings to 34.92% suggests retail investor interest remains robust despite recent price corrections.
Stock Performance: Impressive Long-Term Returns, Recent Volatility
Syrma's stock has delivered exceptional long-term returns whilst exhibiting significant short-term volatility. The three-year return of 180.02% dramatically outpaces the Sensex's 39.16% gain, generating alpha of 140.86 percentage points. The one-year return of 43.83% also substantially exceeds the benchmark's 7.88%, delivering 35.95 percentage points of outperformance.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +8.61% | +0.31% | +8.30% |
| 1 Month | +1.79% | -2.51% | +4.30% |
| 3 Months | -11.20% | -2.86% | -8.34% |
| 6 Months | -2.81% | +1.51% | -4.32% |
| YTD | -1.02% | -3.11% | +2.09% |
| 1 Year | +43.83% | +7.88% | +35.95% |
| 2 Years | +20.72% | +14.77% | +5.95% |
| 3 Years | +180.02% | +39.16% | +140.86% |
However, recent performance reveals growing investor caution. The three-month return of -11.20% underperforms the Sensex's -2.86% decline by 8.34 percentage points, whilst the six-month return of -2.81% lags the benchmark's 1.51% gain. This recent underperformance coincides with the stock's valuation reaching stretched levels and broader market concerns about small-cap valuations.
The stock's high beta of 1.67 indicates significantly greater volatility than the broader market, with a volatility measure of 45.36% compared to the Sensex's 11.23%. This high-risk, high-return profile suits aggressive investors with longer time horizons but may prove uncomfortable for conservative portfolios. The positive Sharpe ratio of 0.97 suggests the returns have adequately compensated for the elevated risk over the past year.
Technical indicators present a mixed picture. The stock trades below all major moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), suggesting technical weakness. The overall trend classification of "SIDEWAYS" as of January 22, 2026, indicates consolidation after the recent decline from peaks. MACD and Dow Theory indicators show mildly bearish signals, whilst moving averages suggest mildly bullish momentum on the weekly timeframe.
Investment Thesis: Growth Story Meets Valuation Reality
Syrma's investment case rests on several compelling foundations. The company operates in a structurally growing industry benefiting from electronics manufacturing shifts to India, government policy support through PLI schemes, and increasing domestic demand. The 36.44% five-year sales CAGR and 38.41% EBIT growth demonstrate the company's ability to capture this opportunity and scale operations effectively.
Mojo Investment Parameters
Valuation: Very Expensive (Premium multiples across metrics)
Quality Grade: Good (Strong growth, zero debt, but weak return ratios)
Financial Trend: Positive (Improving quarterly metrics)
Technical Trend: Sideways (Consolidation after correction)
The company's balance sheet strength provides a significant competitive advantage. With net cash on the books and debt-to-EBITDA of just 2.22 times, Syrma possesses the financial flexibility to invest in capacity expansion, technology upgrades, and potential acquisitions without resorting to dilutive equity raises. The operating cash flow of ₹176.46 crores in FY25 (reversing from negative ₹113 crores in FY24) demonstrates improving cash generation capabilities.
However, several concerns temper enthusiasm. The modest ROE of 7.32% and ROCE of 9.50% suggest capital is not being deployed efficiently enough to justify the premium valuation. The company needs to demonstrate sustained margin improvement and return ratio enhancement as it scales. The recent deterioration in debtors turnover to 2.05 times raises working capital management questions that could impact cash flows.
The valuation premium appears difficult to justify at current levels. Trading at 61x trailing earnings with an EV/EBITDA of 34.87x, the stock prices in substantial growth and margin expansion that may prove challenging to deliver consistently. The recent 20% correction from 52-week highs suggests the market is reassessing these expectations.
Key Strengths & Risk Factors
✅ KEY STRENGTHS
Robust Revenue Growth: 36.44% five-year CAGR with accelerating momentum (37.60% YoY in Q2 FY26)
Margin Expansion: Operating margin improved 154 bps YoY to 10.06%, demonstrating operating leverage
Zero Net Debt: Net cash position provides financial flexibility for growth investments
Structural Tailwinds: Beneficiary of electronics manufacturing shift to India and PLI schemes
Institutional Confidence: 22.35% institutional holdings with insurance companies increasing stake significantly
No Promoter Pledging: Zero pledged shares indicate financial stability
Improving Cash Flow: Operating cash flow turned positive at ₹176.46 crores in FY25
⚠️ KEY CONCERNS
Weak Return Ratios: ROE of 7.32% and ROCE of 9.50% significantly trail peers and sector benchmarks
Premium Valuation: P/E of 61x and EV/EBITDA of 34.87x appear expensive given modest returns
Promoter Stake Reduction: Holding declined 3.80 percentage points over three quarters
Working Capital Concerns: Debtors turnover deteriorated to 2.05 times in H1 FY26
High Volatility: Beta of 1.67 and volatility of 45.36% unsuitable for conservative investors
Recent Underperformance: Down 11.20% over three months, underperforming Sensex by 8.34 percentage points
Growth Sustainability: Questions about maintaining 36% revenue growth as company scales
Outlook: What to Watch
📈 POSITIVE CATALYSTS
ROE Improvement: Sustained improvement in return ratios towards mid-teens levels
Margin Expansion: Operating margins crossing 12% sustainably
Working Capital Management: Debtors turnover improving above 3 times
New Customer Wins: Diversification of revenue base beyond existing clients
Capacity Utilisation: Improving asset turnover and capital efficiency metrics
🚩 RED FLAGS
Further Promoter Reduction: Continued decline in promoter holdings below 40%
Margin Compression: Operating margins falling below 9% due to competitive pressures
Working Capital Deterioration: Debtors days extending beyond current levels
Growth Deceleration: Revenue growth falling below 20% YoY sustainably
FII Exodus: Foreign institutional investors reducing stakes materially
"Syrma's impressive revenue growth and margin expansion showcase operational excellence, but the premium valuation demands sustained improvement in capital efficiency and return ratios to justify current multiples."
Looking ahead, Syrma's trajectory depends on its ability to translate top-line growth into improved capital efficiency. The company must demonstrate that its investments in capacity and capabilities will generate returns commensurate with the premium valuation. Management's focus on margin expansion is encouraging, but investors should monitor whether operating leverage continues to drive profitability improvements.
The electronics manufacturing sector's structural growth story remains intact, providing a favourable backdrop for Syrma's expansion. However, competition is intensifying as both domestic and international players expand Indian operations. The company's ability to differentiate through technology capabilities, customer relationships, and execution quality will determine its competitive positioning.
For existing shareholders, the stock's correction from peaks offers an opportunity to reassess position sizing given valuation concerns. Fresh investors should await either a material valuation correction or sustained evidence of improving return ratios before initiating positions. The risk-reward balance at current levels favours patience over aggressive accumulation.
The Verdict: Promising Growth Story, Patience Required
Score: 57/100
For Fresh Investors: Avoid initiating new positions at current valuations. Wait for either a 15-20% correction towards ₹600 levels or sustained evidence of ROE improving above 12% before considering entry. The growth story is compelling, but valuation premium is excessive given modest return ratios.
For Existing Holders: Continue holding with a trailing stop-loss around ₹650. Monitor quarterly results for sustained margin expansion and working capital improvement. Consider partial profit-booking if stock rallies back towards ₹800-850 range without corresponding fundamental improvement. Reassess position if ROE fails to improve materially over the next 2-3 quarters.
Fair Value Estimate: ₹620-650 (14-18% downside from current levels), based on 45-50x forward earnings assuming 15% profit growth and gradual ROE improvement to 10-12% over the next two years.
Note- ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. All investments carry risk, including the potential loss of principal.
